RxDoctor Payments Data

Zahide Erkmen, MD

Vascular & Interventional Radiology · Germantown, MDNPI 1144291022

Payments from drug & device makers

$258in general payments, 2019–2025

Across 5 payments — averaging $51.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GE HealthCare$147
  • Molli Surgical (US) Inc$54
  • Covidien LP$35
  • Cardiovascular Systems Inc.$22

What the payments were for

  • Food & beverage$258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GE HealthCare1$147
Molli Surgical (US) Inc2$54
Covidien LP1$35
Cardiovascular Systems Inc.1$22

How this compares

$258 in reported general payments places this provider in the 15th percentile of 75 vascular & interventional radiology providers in Maryland.

See all vascular & interventional radiology providers in Maryland

Medicare billing

Part B allowed, 2024
$247,857
Medicare patients
1,000
Services billed
7,147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Germantown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →